Wearable defibrillator jewel P-WCD tested in 322 High-Risk patients

NCT ID NCT05201495

Completed Disease control Sponsor: Element Science, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable defibrillator called the Jewel P-WCD in 322 adults at high risk for sudden cardiac arrest. The device is designed to automatically deliver a shock to restore normal heart rhythm if a dangerous heart rhythm occurs. The main goals were to see how often the device gave unnecessary shocks and how well the skin tolerated the device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Death, Sudden, Cardiac intrinsic cardiomyopathy myocarditis sudden cardiac arrest prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUDDEN CARDIAC ARREST

Contacts and locations

Locations

ACRC Trials - Hunt - PPDS

McKinney, Texas, 75071, United States
Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Cardiology and Medicine Clinic, P.A.

Little Rock, Arkansas, 72204, United States
Central Baptist Hospital

Lexington, Kentucky, 40503, United States
Crystal Run Healthcare - Circuit - PPDS

Middletown, New York, 10941, United States
Emory University

Atlanta, Georgia, 30308, United States
Fuqua Heart Center Piedmont Hospital

Atlanta, Georgia, 30309, United States
Hartford Hospital

Hartford, Connecticut, 06102, United States
Inova Fairfax Hospital

Falls Church, Virginia, 22042, United States
Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
MedStar Georgetown University Hospital

Washington D.C., District of Columbia, 20010, United States
Methodist Hospital

Houston, Texas, 77030, United States
Methodist Le Bonheur

Memphis, Tennessee, 38104, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
New York Presbyterian Brooklyn Methodist Hospital

Brooklyn, New York, 11215, United States
North Mississippi Medical Center

Tupelo, Mississippi, 38801, United States
NorthShore Medical Group

Evanston, Illinois, 60201, United States
Northwell Health

New Hyde Park, New York, 11040, United States
Northwestern University

Chicago, Illinois, 60611, United States
Novant Health

Winston-Salem, North Carolina, 27103, United States
Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States
Parkview Research Center

Fort Wayne, Indiana, 46845, United States
Saint Thomas Research Institute

Nashville, Tennessee, 37203, United States
St. Bernard's Heart and Vascular

Jonesboro, Arkansas, 72401, United States
TriHealth Heart Institute Cardiac and Thoracic

Cincinnati, Ohio, 45242, United States
University of Iowa Hospitals and Clinics

Iowa City, Iowa, 52246, United States
University of Louisville

Louisville, Kentucky, 40202, United States
University of Mississippi Medical Center

Jackson, Missouri, 39216, United States
Virginia Cardiovascular Specialists

Richmond, Virginia, 23225, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.